Significant Ownership of Phoenix Financial Ltd.

Large-stake snapshot 1 signal
Large-stake filing summary
  • Recent SEC Schedule 13D/G filings for Phoenix Financial Ltd. focus on large-stake beneficial ownership disclosures and amendments.
  • Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
/s/ Eli Schwartz - Vice President - Chief Financial Officer
Manager location
Givatayim

Follow Filing Activity

Follow Phoenix Financial Ltd. with Pro and return when a new Schedule 13D/G filing changes the record on this page.

Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.

Significant Ownership of Phoenix Financial Ltd.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ODYS Odysight.ai inc Common Stock, par value $ 0.001 per share 13% $11,737,826 2,157,689 Phoenix Financial Ltd. 31 Mar 2025
GILT Gilat Satellite Networks Ltd Ordinary Shares, NIS 0.20 nominal value 11% $107,939,394 -$10,441,934 8,325,124 -8.8% Phoenix Financial Ltd. 16 Jan 2026
Ares Core Infrastructure Fund Common Shares of Beneficial Interest, par value $0.01 per share 11% 2,394,014 Phoenix Financial Ltd. 20 Feb 2025
TATT TAT TECHNOLOGIES LTD Ordinary Shares, NIS 0.90 par value 8.8% $46,419,396 +$7,843,743 1,142,491 +20% Phoenix Financial Ltd. 31 Mar 2026
ENLT Enlight Renewable Energy Ltd Ordinary Shares, nominal value NIS 0.1 per share 6.7% $636,759,557 -$129,921,511 9,243,135 -17% Phoenix Financial Ltd. 31 Mar 2026
CAMT CAMTEK LTD. Ordinary Shares NIS 0.01 par value 5.1% $326,435,449 2,386,573 Phoenix Financial Ltd. 06 Aug 2026
TSEM TOWER SEMICONDUCTOR LTD Ordinary Shares, par value NIS 15.00 per share 5% $1,531,028,203 5,654,349 Phoenix Financial Ltd. 05 Jun 2026
TEVA Teva Pharmaceutical Industries Ltd Ordinary Shares, par value NIS 0.10 per share 5% $961,741,722 57,383,158 Phoenix Financial Ltd. 14 Jul 2025
SLGL Sol-Gel Technologies Ltd. Ordinary Shares, par value NIS 1.00 per share 5% $11,466,969 161,826 Phoenix Financial Ltd. 02 Jun 2026
ICL ICL Group Ltd. Ordinary Shares, par value NIS 1.00 per share 5% $333,068,539 -$59,430,005 64,298,946 -15% Phoenix Financial Ltd. 13 Aug 2026
NYAX Nayax Ltd. Ordinary shares, par value NIS 0.001 per share 4.9% $118,394,126 -$10,872,356 1,784,119 -8.4% Phoenix Financial Ltd. 05 Aug 2026
PERI Perion Network Ltd. Ordinary Shares, par value NIS 0.03 per share 4.8% $20,524,557 -$6,664,769 1,956,583 -25% Phoenix Financial Ltd. 31 Dec 2025
KMDA KAMADA LTD Ordinary Shares, par value NIS 1.00 each 4.6% $18,698,254 +$18,698,257 2,652,235 Phoenix Financial Ltd. 13 Aug 2026
CSTE Caesarstone Ltd. Ordinary Shares, par value NIS 0.04 per share 4.6% $3,529,062 1,582,539 Phoenix Financial Ltd. 09 Mar 2026
SSYS Stratasys Ltd. Ordinary Shares, par value NIS 0.01 per share 4.3% $41,475,589 3,616,006 Phoenix Financial Ltd. 06 Aug 2025
SMWB SIMILARWEB LTD Ordinary shares, par value 0.01 NIS 2.9% $13,264,676 -$8,853,942 2,502,769 -40% Phoenix Financial Ltd. 18 Feb 2026
ELLO Ellomay Capital Ltd. Ordinary Shares, par value NIS 10.00 per share 0.71% $1,823,111 -$22,484,546 97,964 -92% Phoenix Financial Ltd. 31 Jul 2026
CTV Innovid Corp. Common stock, par value $0.0001 per share 0.08% $387,592 123,437 Phoenix Financial Ltd. 27 Jan 2025

Schedules 13D/G Reported by Phoenix Financial Ltd.:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .